RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000068.xml
PDF herunterladen
Semin intervent Radiol 2017; 34(02): 167-175
DOI: 10.1055/s-0037-1602708
DOI: 10.1055/s-0037-1602708
Review Article
Decision Making: Thermal Ablation Options for Small Renal Masses
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
01. Juni 2017 (online)
Abstract
Renal cell carcinoma is a relatively common tumor, with an estimated 63,000 new cases being diagnosed in the United States in 2016. Surgery, be it with partial or total nephrectomy, is considered the mainstay of treatment for many patients. However, those patients with small renal masses, typically less than 3 to 4 cm in size who are deemed unsuitable for surgery, may be suitable for percutaneous thermal ablation. We review the various treatment modalities, including radiofrequency ablation, microwave ablation, and cryoablation; discuss the advantages and disadvantages of each method; and review the latest data concerning the performance of the various ablative modalities compared with each other, and compared with surgery.
-
References
- 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30
- 2 Pompili M, De Matthaeis N, Saviano A. , et al. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?. Anticancer Res 2015; 35 (01) 325-332
- 3 Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 2002; 178 (03) 699-704
- 4 McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radio frequency ablation of renal cell carcinoma via image guided needle electrodes. J Urol 1999; 161 (02) 599-600
- 5 Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217 (03) 633-646
- 6 Shibata T, Iimuro Y, Yamamoto Y. , et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223 (02) 331-337
- 7 Gill IS, Remer EM, Hasan WA. , et al. Renal cryoablation: outcome at 3 years. J Urol 2005; 173 (06) 1903-1907
- 8 Mack MG, Straub R, Eichler K. , et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging 2001; 26 (04) 369-374
- 9 Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33 (02) 223-231
- 10 Ljungberg B, Bensalah K, Canfield S. , et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015; 67 (05) 913-924
- 11 Thompson RH, Boorjian SA, Lohse CM. , et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179 (02) 468-471 , discussion 472–473
- 12 Chen DY, Uzzo RG. Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. J Natl Compr Canc Netw 2009; 7 (06) 635-642 , quiz 643
- 13 Pavlovich CP, Walther M, Choyke PL. , et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167 (01) 10-15
- 14 Chang X, Zhang F, Liu T. , et al. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes. J Urol 2015; 193 (02) 430-435
- 15 Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63 (03) 486-492
- 16 Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol 2009; 192 (06) 1558-1570
- 17 Gervais DA, Arellano RS, Mueller PR. Percutaneous radiofrequency ablation of renal cell carcinoma. Eur Radiol 2005; 15 (05) 960-967
- 18 Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (01) 72-80
- 19 Goldberg SN. Comparison of techniques for image-guided ablation of focal liver tumors. Radiology 2002; 223 (02) 304-307
- 20 Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 2001; 48 (38) 359-367
- 21 Solbiati L, Ierace T, Goldberg SN. , et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202 (01) 195-203
- 22 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226 (02) 417-424
- 23 Rossi S, Di Stasi M, Buscarini E. , et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167 (03) 759-768
- 24 Zlotta AR, Wildschutz T, Raviv G. , et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997; 11 (04) 251-258
- 25 Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 1999; 10 (07) 907-916
- 26 Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol 2009; 38 (03) 135-143
- 27 Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S179-S186
- 28 Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189 (02) 429-436
- 29 Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 2008; 248 (01) 169-178
- 30 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?. Radiographics 2014; 34 (05) 1344-1362
- 31 Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3 (08) 636-644
- 32 Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (03) 871-879
- 33 Best SL, Park SK, Youssef RF. , et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol 2012; 187 (04) 1183-1189
- 34 Huffman SD, Huffman NP, Lewandowski RJ, Brown DB. Radiofrequency ablation complicated by skin burn. Semin Intervent Radiol 2011; 28 (02) 179-182
- 35 Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25 (Suppl. 01) S69-S83
- 36 Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005; 236 (01) 132-139
- 37 Skinner MG, Iizuka MN, Kolios MC, Sherar MD. A theoretical comparison of energy sources--microwave, ultrasound and laser--for interstitial thermal therapy. Phys Med Biol 1998; 43 (12) 3535-3547
- 38 Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol 1976- 1977; 39 (02) 69-76
- 39 Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178 (01) 47-51
- 40 Ahmed M, Brace CL, Lee Jr FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011; 258 (02) 351-369
- 41 Tabuse K. Basic knowledge of a microwave tissue coagulator and its clinical applications. J Hepatobiliary Pancreat Surg 1998; 5 (02) 165-172
- 42 Brace CL. Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 2009; 38 (02) 61-67
- 43 Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol 2008; 67 (02) 357-361
- 44 Winokur RS, Du JY, Pua BB. , et al. Characterization of in vivo ablation zones following percutaneous microwave ablation of the liver with two commercially available devices: are manufacturer published reference values useful?. J Vasc Interv Radiol 2014; 25 (12) 1939-1946.e1
- 45 Yu J, Liang P, Yu XL. , et al. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology 2014; 270 (03) 880-887
- 46 Kim C, O'Rourke AP, Mahvi DM, Webster JG. Finite-element analysis of ex vivo and in vivo hepatic cryoablation. IEEE Trans Biomed Eng 2007; 54 (07) 1177-1185
- 47 Rewcastle JC, Sandison GA, Muldrew K, Saliken JC, Donnelly BJ. A model for the time dependent three-dimensional thermal distribution within iceballs surrounding multiple cryoprobes. Med Phys 2001; 28 (06) 1125-1137
- 48 Rui J, Tatsutani KN, Dahiya R, Rubinsky B. Effect of thermal variables on human breast cancer in cryosurgery. Breast Cancer Res Treat 1999; 53 (02) 185-192
- 49 Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60 (02) (Suppl. 01) 40-49
- 50 Atwell TD, Farrell MA, Callstrom MR. , et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol 2007; 188 (05) 1195-1200
- 51 Rosenberg MD, Kim CY, Tsivian M. , et al. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. AJR Am J Roentgenol 2011; 196 (04) 935-939
- 52 Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer 2008; 113 (10) 2671-2680
- 53 Pech M, Janitzky A, Wendler JJ. , et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 2011; 34 (01) 132-138
- 54 Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol 2013; 16 (04) 192-200
- 55 Deodhar A, Dickfeld T, Single GW. , et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol 2011; 196 (03) W330-5
- 56 Wendler JJ, Porsch M, Nitschke S. , et al. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials 2015; 43: 10-19
- 57 Nicholson ML, Wheatley TJ, Doughman TM. , et al. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int 2000; 58 (01) 390-395
- 58 Cantwell CP, Wah TM, Gervais DA. , et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol 2008; 19 (07) 1034-1040
- 59 Boss A, Clasen S, Kuczyk M. , et al. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. AJR Am J Roentgenol 2005; 185 (06) 1627-1631
- 60 Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217 (03) 665-672
- 61 Farrell MA, Charboneau WJ, DiMarco DS. , et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003; 180 (06) 1509-1513
- 62 Goldberg SN, Hahn PF, Tanabe KK. , et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 1998; 9 (1, Pt 1): 101-111
- 63 El Dib R, Touma NJ, Kapoor A. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int 2012; 110 (04) 510-516
- 64 Atwell TD, Schmit GD, Boorjian SA. , et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2013; 200 (02) 461-466
- 65 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (01) 64-71
- 66 Gupta A, Raman JD, Leveillee RJ. , et al. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol 2009; 23 (07) 1099-1105
- 67 Brashears III JH, Raj GV, Crisci A. , et al. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. J Urol 2005; 173 (06) 2160-2165
- 68 Sung GT, Gill IS, Hsu TH. , et al. Effect of intentional cryo-injury to the renal collecting system. J Urol 2003; 170 (2, Pt 1): 619-622
- 69 Thompson RH, Atwell T, Schmit G. , et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015; 67 (02) 252-259
- 70 Campbell SC, Novick AC, Belldegrun A. , et al; Practice Guidelines Committee of the American Urological Association. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182 (04) 1271-1279
- 71 Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol 2008; 179 (04) 1227-1233 , discussion 1233–1234
- 72 Lorentzen T. A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol 1996; 3 (07) 556-563
- 73 Arata MA, Nisenbaum HL, Clark TW, Soulen MC. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response?. J Vasc Interv Radiol 2001; 12 (04) 455-458
- 74 Haemmerich D, Staelin ST, Tungjitkusolmun S, Lee Jr FT, Mahvi DM, Webster JG. Hepatic bipolar radio-frequency ablation between separated multiprong electrodes. IEEE Trans Biomed Eng 2001; 48 (10) 1145-1152
- 75 Haemmerich D, Chachati L, Wright AS, Mahvi DM, Lee Jr FT, Webster JG. Hepatic radiofrequency ablation with internally cooled probes: effect of coolant temperature on lesion size. IEEE Trans Biomed Eng 2003; 50 (04) 493-500
- 76 Lu MD, Chen JW, Xie XY. , et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221 (01) 167-172
- 77 Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17 (06) 1471-1474
- 78 MacLennan S, Imamura M, Lapitan MC. , et al; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012; 61 (05) 972-993
- 79 Whitson JM, Harris CR, Meng MV. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int 2012; 110 (10) 1438-1443 , discussion 1443
- 80 Stern JM, Svatek R, Park S. , et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007; 100 (02) 287-290
- 81 Schmit GD, Thompson RH, Kurup AN. , et al. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol 2013; 189 (01) 30-35
- 82 Canter D, Kutikov A, Manley B. , et al. Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 2011; 78 (05) 1089-1094
- 83 Kutikov A, Smaldone MC, Egleston BL. , et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol 2011; 60 (02) 241-248
- 84 Bruner B, Breau RH, Lohse CM, Leibovich BC, Blute ML. Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int 2011; 108 (01) 67-72
- 85 Simhan J, Smaldone MC, Tsai KJ. , et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol 2011; 60 (04) 724-730